B · Normal
[U.S. FDA terminates rapid drug review program] November 12th, the U.S. Food and Drug Administration (FDA) has terminated a rapid drug review program launched in June 2025. FDA leadership has informed relevant parties that the National Voucher Program will no longer be advanced, but applications are still open.
medicine 🕐 2026-11-12 19:50
#ROG #medicine #Pharmaceutical business
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

On November 12, sources and documents showed that the U.S. FDA had shelved the f 11-12 19:01 On November 12, Eli Lilly’s stock price rose 3% before the market opened as Chin 11-12 17:55 [Henan issues notice to further standardize centralized drug procurement] On Nov 11-12 16:25 On November 12, Hungarian pharmaceutical company Gilead (Richter) signed a women 11-12 15:12 [Yunnan: Explore the development of “TCM + AI” and promote the application of TC 11-12 11:47 [Fujian: Build 10 artificial intelligence scientific research and innovation pla 11-12 11:25

Comments

0/500
Captcha (click to refresh)
No comments yet